WellPoint (WLP) Tops Q3 EPS by 9c; Boosts FY14 EPS Outlook

WellPoint (NYSE: WLP) reported Q3 EPS of $2.36, $0.09 better than the analyst estimate of $2.27. Revenue for the quarter came in at $18.4 billion versus the consensus estimate of $18.72 billion.

Medical enrollment totaled approximately 37.5 million members at September 30, 2014, an increase of approximately 2.0 million members, or 5.7 percent, from 35.5 million at September 30, 2013. Commercial & Specialty Business enrollment increased by 1.3 million medical members as the company experienced growth in the Local Group, National and Individual markets. Enrollment also grew in the Medicaid and Federal Employee Program business by 754,000 and 10,000, respectively, partially offset by a decline in the Medicare business of 39,000.

Medical enrollment increased by 259,000 members, or 0.7 percent, sequentially during the third quarter of 2014, primarily due to enrollment gains in the Medicaid, Local Group and National businesses, partially offset by a decline in enrollment in the Individual business.

WellPoint sees FY2014 EPS of $8.75-$8.85, versus the consensus of $8.72.

For earnings history and earnings-related data on WellPoint (WLP) click here.

You May Also Be Interested In

• Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates
• Royal Caribbean (RCL) tops Q1 expectations, raises full-year earnings guidance
• Carrier Global (CARR) Tops Q1 EPS by 12c ; Offers Guidance